Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Vokinger KN"" wg kryterium: Autor


Tytuł :
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe.
Autorzy :
Vokinger KN; Institute of Law, and Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Hwang TJ; Institute of Law, and Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Daniore P; Institute of Law, and Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland.
Lee CC; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Tibau A; Oncology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, and.; Oncology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Barcelona, Catalonia, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Grischott T; Institute of Primary Care, University Hospital Zurich and.; Institute of Primary Care, University Hospital Zurich/University of Zurich, Zurich, Switzerland.
Rosemann TJ; Institute of Primary Care, University Hospital Zurich and.; Institute of Primary Care, University Hospital Zurich/University of Zurich, Zurich, Switzerland.
Kesselheim AS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Jul 01. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Continual learning in medical devices: FDA's action plan and beyond.
Autorzy :
Vokinger KN; Institute of Law, University of Zurich, Ramistrasse 74, 8001 Zurich, Switzerland; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kerstinnoelle.vokinger@usz.ch.
Feuerriegel S; ETH AI Center, ETH Zurich, Zurich, Switzerland.
Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
The Lancet. Digital health [Lancet Digit Health] 2021 Jun; Vol. 3 (6), pp. e337-e338. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article
MeSH Terms :
Algorithms*
Equipment and Supplies*
Government Regulation*
Machine Learning*
Medical Informatics*/instrumentation
Medical Informatics*/legislation & jurisprudence
Software*/legislation & jurisprudence
Delivery of Health Care ; Feedback ; Humans ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
Autorzy :
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.
Daniore P; Institute of Law, University of Zurich, Switzerland.
Vokinger KN; Institute of Law, University of Zurich, Switzerland. Electronic address: kerstinnoelle.vokinger@usz.ch.
Pokaż więcej
Źródło :
The Lancet. Digital health [Lancet Digit Health] 2021 Mar; Vol. 3 (3), pp. e195-e203. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Comparative Study; Journal Article; Review
MeSH Terms :
Artificial Intelligence*
Biomedical Technology*
Equipment and Supplies*
Government Regulation*
Machine Learning*
Databases, Factual ; Device Approval ; Europe ; Humans ; Radiology ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Patients' access to drugs with rebates in Switzerland - Empirical analysis and policy implications for drug pricing in Europe.
Autorzy :
Carl DL; Institute of Law, University of Zurich, Ramistrasse 74, Zurich, Switzerland.
Vokinger KN; Institute of Law, University of Zurich, Ramistrasse 74, Zurich, Switzerland.
Pokaż więcej
Źródło :
The Lancet regional health. Europe [Lancet Reg Health Eur] 2021 Feb 17; Vol. 3, pp. 100050. Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study.
Autorzy :
Hwang TJ; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA .; Laboratory for Technology, Markets and Regulation, University of Zurich, Zurich, Switzerland.
Ross JS; Section of General Internal Medicine, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT, USA.; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.
Vokinger KN; Laboratory for Technology, Markets and Regulation, University of Zurich, Zurich, Switzerland.; Institute of Law, University of Zurich, Zurich, Switzerland.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2020 Oct 07; Vol. 371, pp. m3434. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Approval*/methods
Drug Approval*/statistics & numerical data
Drug Evaluation*/methods
Drug Evaluation*/statistics & numerical data
Drug Information Services*/organization & administration
Drug Information Services*/standards
Drug Information Services*/statistics & numerical data
Information Dissemination*
Product Surveillance, Postmarketing*/methods
Product Surveillance, Postmarketing*/statistics & numerical data
Europe ; Humans ; Program Development ; Quality Improvement ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł :
Digital health and the COVID-19 epidemic: an assessment framework for apps from an epidemiological and legal perspective.
Autorzy :
Vokinger KN; Faculty of Law, University of Zurich, Switzerland.
Nittas V; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland.
Witt CM; Institute for Complementary and Integrative Medicine, University Hospital Zurich, Switzerland.
Fabrikant SI; Department of Geography, University of Zurich, Switzerland.
von Wyl V; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland / Institute for Implementation Science in Health Care, University of Zurich, Switzerland.
Pokaż więcej
Źródło :
Swiss medical weekly [Swiss Med Wkly] 2020 May 17; Vol. 150, pp. w20282. Date of Electronic Publication: 2020 May 17 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus*
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Mobile Applications*
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Smartphone*
Telemedicine*
Checklist/*standards
Pandemics/*prevention & control
Betacoronavirus ; COVID-19 ; Contact Tracing ; Geographic Information Systems ; Humans ; Medical Informatics Applications ; Privacy ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost-benefit analysis.
Autorzy :
Vokinger KN; Institute of Law, University of Zurich, Zurich, Switzerland; Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kerstinnoelle.vokinger@usz.ch.
Hwang TJ; Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Grischott T; Institute of Primary Care, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Reichert S; Institute of Law, University of Zurich, Zurich, Switzerland; Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland.
Tibau A; Oncology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Rosemann T; Institute of Primary Care, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 May; Vol. 21 (5), pp. 664-670.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost-Benefit Analysis*
Drug Costs*
Medical Oncology/*economics
Neoplasms/*economics
Antineoplastic Agents/economics ; Antineoplastic Agents/therapeutic use ; England/epidemiology ; Europe/epidemiology ; France/epidemiology ; Germany/epidemiology ; Humans ; Neoplasms/epidemiology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Accessibility of cancer drugs in Switzerland: Time from approval to pricing decision between 2009 and 2018.
Autorzy :
Vokinger KN; Institute of Law, and Lab for Technology, Markets and Regulation, University of Zurich, Zurich, Switzerland; Institute for Primary Care, University Hospital of Zurich and University of Zurich, Zurich, Switzerland. Electronic address: Kerstinnoelle.vokinger@usz.ch.
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich / University of Zurich, Department of Nuclear Medicine, University Hospital of Zurich/University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
Health policy (Amsterdam, Netherlands) [Health Policy] 2020 Mar; Vol. 124 (3), pp. 261-267. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Drug Costs*
Neoplasms*/drug therapy
Costs and Cost Analysis ; Drug Approval ; Humans ; Switzerland
Czasopismo naukowe
Tytuł :
Lost in Anonymization - A Data Anonymization Reference Classification Merging Legal and Technical Considerations.
Autorzy :
Vokinger KN; Kerstin N. Vokinger, M.D., J.D., Ph.D., LL.M., is an Assistant Professor at the University of Zurich, Switzerland. Daniel J. Stekhoven, Ph.D., is at NEXUS, Personalized Health Technologies, Swiss Federal Institute of Technology, (ETH) in Zu-rich, Switzerland. Michael Krauthammer, M.D., Ph.D., is Professor for Medical Informatics at the University of Zurich, Switzerland.
Stekhoven DJ; Kerstin N. Vokinger, M.D., J.D., Ph.D., LL.M., is an Assistant Professor at the University of Zurich, Switzerland. Daniel J. Stekhoven, Ph.D., is at NEXUS, Personalized Health Technologies, Swiss Federal Institute of Technology, (ETH) in Zu-rich, Switzerland. Michael Krauthammer, M.D., Ph.D., is Professor for Medical Informatics at the University of Zurich, Switzerland.
Krauthammer M; Kerstin N. Vokinger, M.D., J.D., Ph.D., LL.M., is an Assistant Professor at the University of Zurich, Switzerland. Daniel J. Stekhoven, Ph.D., is at NEXUS, Personalized Health Technologies, Swiss Federal Institute of Technology, (ETH) in Zu-rich, Switzerland. Michael Krauthammer, M.D., Ph.D., is Professor for Medical Informatics at the University of Zurich, Switzerland.
Pokaż więcej
Źródło :
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2020 Mar; Vol. 48 (1), pp. 228-231.
Typ publikacji :
Journal Article
MeSH Terms :
Data Anonymization/*legislation & jurisprudence
Personally Identifiable Information/*legislation & jurisprudence
Electronic Health Records ; European Union ; Humans ; Medical Informatics ; Switzerland ; United States
Czasopismo naukowe
Tytuł :
Lifecycle Regulation of Artificial Intelligence- and Machine Learning-Based Software Devices in Medicine.
Autorzy :
Hwang TJ; Harvard Medical School, Boston, Massachusetts.; Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland.
Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Vokinger KN; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Institute of Law and Laboratory for Technology, Markets, and Regulation, University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
JAMA [JAMA] 2019 Dec 17; Vol. 322 (23), pp. 2285-2286.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Artificial Intelligence*
Government Regulation*
Machine Learning*
Software/*legislation & jurisprudence
Humans ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Application of orphan drug designation to cancer treatments (2008-2017): a comprehensive and comparative analysis of the USA and EU.
Autorzy :
Vokinger KN; Academic Chair for Public Law, Health Law, and Digitalization, Institute of Law, University of Zurich, Zurich, Switzerland kerstinnoelle.vokinger@usz.ch.; Institute for Primary Care and Health Services Research, University Hospital of Zurich/University of Zurich, Zurich, Switzerland.; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2019 Oct 10; Vol. 9 (10), pp. e028634. Date of Electronic Publication: 2019 Oct 10.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Orphan Drug Production*
Antineoplastic Agents/*therapeutic use
Drug Approval/*organization & administration
Neoplasms/*drug therapy
European Union ; Humans ; United States
Czasopismo naukowe
Tytuł :
[Clinical Practice Guidelines: An Ambiguous Term With Potentially Unexpected Legal Consequences].
Autorzy :
Ulyte A; 1 Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich.
Vokinger KN; 2 Rechtswissenschaftliches Institut, Universität Zürich und Institut für Hausarztmedizin, Universität Zürich.
Dressel H; 1 Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich.; 3 Abteilung Arbeits- und Umweltmedizin, Institut für Epidemiologie, Biostatistik und Prävention und Poliklinik für Innere Medizin, Universität Zürich und Universitätsspital Zürich.
Pokaż więcej
Transliterated Title :
Klinische Leitlinien: ein mehrdeutiger Begriff mit potenziell unerwarteten juristischen Konsequenzen.
Źródło :
Praxis [Praxis (Bern 1994)] 2019 Aug; Vol. 108 (10), pp. 673-677.
Typ publikacji :
Journal Article
MeSH Terms :
Practice Guidelines as Topic*
Terminology as Topic*
Jurisprudence ; Switzerland
Czasopismo naukowe
Tytuł :
Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs.
Autorzy :
Vokinger KN; Academic Chair for Public Law, Health Law, Digitalization and Health Policy, Faculty of Law, University of Zurich / Institute for Primary Care, University Hospital of Zurich and University of Zurich, Zurich, Switzerland; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: .
Kesselheim AS; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Health policy (Amsterdam, Netherlands) [Health Policy] 2019 Aug; Vol. 123 (8), pp. 721-727. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*standards
Clinical Trials as Topic/*standards
Drug Approval/*organization & administration
Humans ; Neoplasms/drug therapy ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Vertebral body insufficiency fractures: detection of vertebrae at risk on standard CT images using texture analysis and machine learning.
Autorzy :
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland. .
Mannil M; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Becker AS; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Vokinger KN; University Hospital of Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Finkenstaedt T; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Osterhoff G; Department of Trauma, University Hospital Zurich, Zurich, Switzerland.
Fischer MA; Department of Radiology, University Hospital Balgrist, University of Zurich, Zurich, Switzerland.
Guggenberger R; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2019 May; Vol. 29 (5), pp. 2207-2217. Date of Electronic Publication: 2018 Dec 05.
Typ publikacji :
Journal Article
MeSH Terms :
Machine Learning*
Fractures, Stress/*diagnosis
Lumbar Vertebrae/*injuries
Spinal Fractures/*diagnosis
Thoracic Vertebrae/*injuries
Tomography, X-Ray Computed/*methods
Aged ; Aged, 80 and over ; Bone Density ; Case-Control Studies ; Female ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Male ; Middle Aged ; ROC Curve ; Retrospective Studies ; Thoracic Vertebrae/diagnostic imaging
Czasopismo naukowe
Tytuł :
Evaluating New Rules on Transparency in Cancer Research and Drug Development.
Autorzy :
Hwang TJ; Harvard Medical School, Boston, Massachusetts.
Vokinger KN; University of Zürich and University Hospital Zürich, Zürich, Switzerland.
Sachs RE; Washington University School of Law, St Louis, Missouri.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2019 Apr 01; Vol. 5 (4), pp. 461-462.
Typ publikacji :
Journal Article
MeSH Terms :
Biomedical Research/*ethics
Clinical Trials as Topic/*ethics
Canada ; Drug Development ; Government Agencies ; Humans ; Neoplasms/drug therapy ; Public Policy ; United States
Czasopismo naukowe
Tytuł :
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
Autorzy :
Hwang TJ; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Jain N; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Lauffenburger JC; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Vokinger KN; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Faculty of Medicine, University of Zürich and University Hospital Zürich, Zürich, Switzerland.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA internal medicine [JAMA Intern Med] 2019 Mar 01; Vol. 179 (3), pp. 374-380.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms :
Cost Sharing*
Medicare Part B/*economics
Medicare Part D/*economics
Prescription Drugs/*economics
Aged ; Female ; Humans ; Male ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł :
Applicability of color-coded computed tomography images in lung volume reduction surgery planning.
Autorzy :
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Caviezel C; Department of Thoracic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Martini K; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Vokinger KN; Academic Chair for Public Law, Health Law, Digitalization, and Health Policy, Law School, University of Zurich, Zurich, Switzerland.
Wetzler IR; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Tutic-Horn M; Department of Thoracic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Weder W; Department of Thoracic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Frauenfelder T; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
Journal of thoracic disease [J Thorac Dis] 2019 Mar; Vol. 11 (3), pp. 766-776.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
[Federal Supreme Court Decisions in Medical Law (2000-2017) - Overview and Selected Case Reports].
Autorzy :
Vokinger KN; 1 Institut für Hausarztmedizin, Universitätsspital Zürich.
Mühlematter UJ; 2 Institut für diagnostische und interventionelle Radiologie, Universitätsspital Zürich.
Pokaż więcej
Transliterated Title :
Bundesgerichtliche Urteile zum Arztrecht (2000–2017) – Überblick, ausgewählte Kasuistik und Würdigung.
Źródło :
Praxis [Praxis (Bern 1994)] 2019; Vol. 108 (3), pp. 199-203.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Gynecology*
Internal Medicine*
Physicians*
Supreme Court Decisions*
Female ; Humans ; Pregnancy ; United States
Czasopismo naukowe
Tytuł :
Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment.
Autorzy :
Gyawali B; 1 Program on Regulation, Therapeutics, and Law, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Hwang TJ; 1 Program on Regulation, Therapeutics, and Law, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Vokinger KN; 1 Program on Regulation, Therapeutics, and Law, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; 2 Institute for Primary Care and Health Outcomes Research, University of Zürich, Zürich, Switzerland.
Booth CM; 3 Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; 4 Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
Amir E; 5 Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Ontario, Canada.
Tibau A; 6 Department of Oncology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2019 Jan; Vol. 39, pp. 374-387. Date of Electronic Publication: 2019 May 17.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Drug Development*/methods
Patient-Centered Care*/methods
Clinical Trials as Topic ; Drug Approval ; Europe ; Humans ; Neoplasms/drug therapy ; Patient Participation ; Quality of Life ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Correction to: impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous F-choline PET/MRI for prostate cancer.
Autorzy :
Muehlematter UJ; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland. .; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland. .
Nagel HW; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Becker A; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Mueller J; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Vokinger KN; University Hospital Zurich, Zurich, Switzerland.
de Galiza Barbosa F; Department of Diagnostic Imaging, Sirio Libanes Hospital, Sao Paulo, Brazil.
Ter Voert EEGT; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Veit-Haibach P; Department Joint Medical Imaging, Toronto General Hospital, Toronto, ON, Canada.; University of Toronto, Toronto, ON, Canada.
Burger IA; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
EJNMMI research [EJNMMI Res] 2018 Jul 27; Vol. 8 (1), pp. 68. Date of Electronic Publication: 2018 Jul 27.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies